KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Treasury Shares (2017 - 2025)

Historic Treasury Shares for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $3.0 million.

  • Twist Bioscience's Treasury Shares rose 1478.66% to $3.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 million, marking a year-over-year increase of 1478.66%. This contributed to the annual value of $1.9 million for FY2025, which is 152.75% down from last year.
  • Latest data reveals that Twist Bioscience reported Treasury Shares of $3.0 million as of Q4 2025, which was up 1478.66% from $1.9 million recorded in Q3 2025.
  • Twist Bioscience's Treasury Shares' 5-year high stood at $3.0 million during Q4 2025, with a 5-year trough of $736.0 in Q1 2021.
  • Over the past 5 years, Twist Bioscience's median Treasury Shares value was $1.8 million (recorded in 2023), while the average stood at $1.6 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first plummeted by 9855.41% in 2021, then soared by 17313369.57% in 2022.
  • Over the past 5 years, Twist Bioscience's Treasury Shares (Quarter) stood at $1605.0 in 2021, then soared by 113171.03% to $1.8 million in 2022, then skyrocketed by 33.06% to $2.4 million in 2023, then grew by 8.47% to $2.6 million in 2024, then grew by 14.79% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q4 2025, $1.9 million for Q3 2025, and $2.1 million during Q2 2025.